Table 1

Characteristics of patients whose surgeries had the least amount of overlap (bottom 40% of patients with overlapping surgeries) and the most amount of overlap (top 10% of patients with overlapping surgeries).

VariableLeast Overlap (N = 520)Most Overlap (N = 131)P Value
Age (y), mean (range)60.30 (24–88)63.90 (26–87)0.001
Gender, n (%)0.96
 Male225 (43.3%)57 (43.5%)
 Female295 (56.7%)74 (56.5%)
Race, n (%) Asian6 (1.2%)1 (0.8%)0.55
 Black55 (10.6%)12 (9.2%)
 White441 (84.8%)117 (89.3%)
 Hispanic4 (0.8%)0 (0%)
 Unknown10 (1.9%)0 (0%)
 Other2 (0.4%)1 (0.8%)
 East Indian2 (0.4%)0 (0%)
Insurance, n (%)0.017     
 Commercial20 (3.8%)2 (1.5%)
 Medicare213 (41.0%)73 (55.7%)
 Medicaid26 (5.0%)4 (3.1%)
 Managed care192 (36.9%)33 (25.2%)
 Blue cross69 (13.3%)19 (14.5%)
Tobacco use within past 12 mo, n (%)0.08
 Yes81 (15.6%)11 (8.4%)
 No437 (84.0%)120 (91.6%)
 Unknown2 (0.4%)0 (0%)
Fasting blood glucose (mg/dL), mean (range)133.95 (60–303)127.84 (79–209)0.32
Surgeries before index operation (count), mean (range)
 Ever0.58 (0–12)0.61 (0–14)0.39
 90 d Prior0.07 (0–5)0.02 (0–1)0.13
Direct cost of operative supplies and implants ($), mean (range)10,254 (116–50,894)6696 (342–27,592)<0.001
Length of hospital stay (h), mean (range)104.64 (24–1070)96.59 (26–563)0.006
Length of follow-up (mo), mean (range)43.62 (0.5–83.11)38.24 (0.7–80.74)0.018
Non-neurosurgical operations 30 d after index operation (count), mean (range)0.07 (0–3)0.09 (0–2)0.31
  • Note: Statistically significant (P < 0.05) values are bolded.